Literature DB >> 7074895

Chloroquine and its metabolites in human cord blood, neonatal blood, and urine after maternal medication.

E E Essien, G C Afamefuna.   

Abstract

Chloroquine, its N-dealkylated metabolites, and chloroquine N-oxides were detected in the urine of pregnant women who were receiving chloroquine medication whereas chloroquine and its nonpolar metabolites, desethyl- and didesethylchloroquine and 7-chloro-4-aminoquinoline, have been found in the neonates' urine, blood, and cord blood. We used thin-layer chromatography to separate chloroquine and its metabolites after their extraction from biological fluids. These compounds were identified by comparing their chromatographic and ultraviolet spectrophotometric characteristics with those of reference compounds. That chloroquine and its relatively nonpolar metabolites (including one without the alkyl side-chain, 7-chloro-4-aminoquinoline) cross the placenta is demonstrated by the presence of these compounds in the cord blood, neonatal systemic blood, and neonatal urine. The selective transfer of the compounds in the cord blood, neonatal system blood, and neonatal urine. The selective transfer of the compounds across the placenta and the clinical implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7074895

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

Review 1.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

3.  The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects.

Authors:  M Frisk-Holmberg; Y Bergqvist; E Termond; B Domeij-Nyberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Inoculum effect with chloroquine and Plasmodium falciparum.

Authors:  I Y Gluzman; P H Schlesinger; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

5.  Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice.

Authors:  Els Keyaerts; Sandra Li; Leen Vijgen; Evelien Rysman; Jannick Verbeeck; Marc Van Ranst; Piet Maes
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

Review 6.  Models for placental transfer studies of drugs.

Authors:  P Bourget; C Roulot; H Fernandez
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

Review 7.  Management of relapsing Plasmodium vivax malaria.

Authors:  Cindy S Chu; Nicholas J White
Journal:  Expert Rev Anti Infect Ther       Date:  2016-08-31       Impact factor: 5.091

Review 8.  Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019.

Authors:  Margaux Louchet; Jeanne Sibiude; Gilles Peytavin; Olivier Picone; Jean-Marc Tréluyer; Laurent Mandelbrot
Journal:  Am J Obstet Gynecol MFM       Date:  2020-06-22

Review 9.  Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection.

Authors:  Melanie R Nicol; Abhay Joshi; Matthew L Rizk; Philip E Sabato; Radojka M Savic; David Wesche; Jenny H Zheng; Jack Cook
Journal:  Clin Pharmacol Ther       Date:  2020-09-01       Impact factor: 6.903

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.